Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
38
datasets available to search
ShareScore release 0.9.0
Dataset results
38 results for “surveillance monitoring”
Air Quality Monitoring and Health Surveillance of Workers in the Photocopier Units
ClinicalTrials.gov study NCT01289184. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Digital Applications to Monitor Novel Coronavirus Disease and Response in Colombia - Syndromic and Vaccination Surveillance
ClinicalTrials.gov study NCT05764174. IPD Sharing: NO. Countries: 1. Publications: 0.
Canadian Rotavirus Surveillance Through the Immunization Monitoring Program Active (IMPACT)
ClinicalTrials.gov study NCT01633190. IPD Sharing: NO. Countries: 1. Publications: 0.
A Pilot Surveillance Study to Monitor Natural Killer Cells and Circulating Tumor Cells in Women With Previously Treated Non-metastatic Triple Negative Breast Cancer and Women With Previously Treated N
ClinicalTrials.gov study NCT02639832. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Determination of the Clinical Impact of Continuous Surveillance Monitoring (SM) and Utility of IPI.
ClinicalTrials.gov study NCT03050983. IPD Sharing: NO. Countries: 1. Publications: 0.
Evaluation of Proteome Multimarker Panel With Multiple Reaction Monitoring as a Surveillance for Hepatocellular Carcinoma
ClinicalTrials.gov study NCT05756699. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Safe Surveillance of PCI Under Mechanical Circulatory Support With the Saranas Early Bird Bleed Monitoring System
ClinicalTrials.gov study NCT05077657. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Implementing Hospital-based Active Surveillance Procedures for Vaccine Safety Monitoring at IMSS Hospitals in Mexico
ClinicalTrials.gov study NCT00436358. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Resting Heart Rate Monitoring for Optimized Treatment and Surveillance of Hyperthyroidism
ClinicalTrials.gov study NCT04932135. IPD Sharing: NO. Countries: 1. Publications: 0.
Surveillance of High-grade Non-muscle Invasive Bladder Tumours Using the Xpert Bladder Cancer Monitor
ClinicalTrials.gov study NCT04100733. IPD Sharing: Not stated. Countries: 1. Publications: 0.
An Open Label, Multi-centre, Non-interventional Post-marketing Surveillance to Monitor the Safety and/or Efficacy of AVANDAMET Between June 2004 and January 2010
ClinicalTrials.gov study NCT01294553. IPD Sharing: Not stated. Countries: 0. Publications: 0.
ER/LA Opioid Analgesics - Surveillance Monitoring of State Medical Examiner Databases
ClinicalTrials.gov study NCT02897414. IPD Sharing: Not stated. Countries: 0. Publications: 0.
Post Marketing Surveillance to Monitor the Safety and Efficacy of Metalyse® in Korean Patients With Acute Myocardial Infarction
ClinicalTrials.gov study NCT02206646. IPD Sharing: Not stated. Countries: 0. Publications: 0.
Surveillance Monitoring of Opioid Abuse in Poison and Drug Treatment Centers
ClinicalTrials.gov study NCT02871232. IPD Sharing: Not stated. Countries: 0. Publications: 0.
Surveillance Monitoring on General Wards
ClinicalTrials.gov study NCT03271216. IPD Sharing: Not stated. Countries: 0. Publications: 0.
Post-marketing Surveillance Study With MicardisPlus® in Treatment of Morning Hypertension (Self-monitored by Patient)
ClinicalTrials.gov study NCT02243566. IPD Sharing: Not stated. Countries: 0. Publications: 0.
Dataset related to article "Xpert Bladder Cancer Monitor May Avoid Cystoscopies in Patients Under "Active Surveillance" for Recurrent Bladder Cancer (BIAS Project): Longitudinal Cohort Study "
<p>This record contains raw data related to article “Xpert Bladder Cancer Monitor May Avoid Cystoscopies in Patients Under "Active Surveillance" for Recurrent Bladder Cancer (BIAS Project): Longitudinal Cohort Study"</p> <p>Abstract</p> <p><strong>Objectives: </strong> To test the hypothesis that patients under active surveillance (AS) for Non-muscle Invasive Bladder Cancer (NMIBC) who were negative on longitudinal re-testing by the Xpert<sup>®</sup> Bladder Cancer Monitor (Xpert BC Monitor) assay may avoid unnecessary cystoscopies and urine cytology (UC).</p> <p><strong>Subjects/patients or materials and methods: </strong> This is a prospective cohort study of patients enrolled in the AS protocol for recurrent NMIBC (Bladder Cancer Italian Active Surveillance, BIAS project), whose urine samples were analyzed by Xpert BC Monitor upon entry in the study (T0). Patients who had a negative Xpert test and did not fail AS, underwent additional Xpert tests after 4 (T1), 8 (T2), and 12 (T3) months. The clinical utility of Xpert was assessed by determining the number of cystoscopies and UC that could be avoided within 1 year.</p> <p><strong>Results: </strong> Overall, 139 patients were tested with Xpert at T0. Median follow-up was 23 (IQR 17-27) months. Sixty-eight (48.9%) patients failed AS, 65 (46.7%) are currently on AS, and 6 (4.3%) were lost at follow-up. At T0 57 (41.0%) patients had a negative test and 36 (63.2%) are still in AS. In patients with 2 consecutives negative Xpert tests, we could have avoided 73.9% of unnecessary cystoscopies, missing 26.4% failure, up to avoid all cystoscopies with 4 negative tests missing only 12% of failure. All the patients with negative Xpert had negative UC. Failure-free-survival at median follow-up (23 month) stratified for having 0, 1, or ≥2 negative tests was 67.0, 55.1. and 84.1, respectively.</p> <p><strong>Conclusion: </strong> Our findings suggest that Xpert BC Monitor assay, when it is longitudinally repeated, could significantly reduce the number of unnecessary cystoscopies and UC during their follow-up.</p> <p> </p>
Genomic surveillance of SARS-CoV-2 in healthcare workers: a critical sentinel group for monitoring the SARS-CoV-2 variant shift
<p>Figure S1. Phylogenetic reconstruction of SARS-CoV-2 sequences distinguished between general population and healthcare workers. Samples correspond to the period of November 17th, 2021 and February 21st, 2022. The phylogenetic tree was reconstructed with 1,000 iterations for Ultra-Fast Bootstrap and SH-like approximate likelihood ratio test (SH-aLRT). Reference (SARS-CoV-2 reference genome - NC_045512).</p>
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.